Researchers at the National Institutes of Health have analyzed results from 20 years of research on people with autoimmune lymphoproliferative syndrome. Their report describes an easy-to-measure biomarker and strategies to improve treatment.
Read MoreRapid influenza detection tests are known to suffer from lack of sensitivity, but IVD manufacturers and clinical laboratories are working on new offerings that promise to improve patient diagnoses and better protect public health.
Read More
Qiagen NV and Exosome Diagnostics Inc. have expanded their existing strategic partnership to develop a first-in-class, noninvasive molecular diagnostic for use in detecting and monitoring actionable genetic mutations in lung cancer patients.
Read MoreFollowing a recent Caribbean outbreak of the mosquito-borne Chikungunya virus, Vela Diagnostics has released a research use only test to identify the disease. Chikungunya currently has no vaccine or cure.
Read More
The Alere i test can detect the influenza A and B virus in 15 minutes, preventing unnecessary prescribing of antibiotics due to misdiagnosis. The test is currently available in Europe and under FDA review in the United States.
Read More